Ascelia Pharma AB (publ) (STO:ACE)
Sweden · Delayed Price · Currency is SEK 0.5800
-0.0040 (-0.68%)
Aug 13, 2026, 5:24 PM CET
Ascelia Pharma AB Market Cap
Ascelia Pharma AB has a market cap or net worth of 77.98 million as of August 13, 2026. Its market cap has decreased by -86.03% in one year.
Market Cap
77.98M
Enterprise Value
44.79M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.58
ChartMarket Cap Chart
Since March 13, 2019, Ascelia Pharma AB's market cap has decreased from 562.35M to 77.98M, a decrease of -86.13%. That is a compound annual growth rate of -23.36%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 77.98M | -80.88% |
| Dec 30, 2025 | 407.88M | 45.35% |
| Dec 30, 2024 | 280.63M | 146.68% |
| Dec 29, 2023 | 113.76M | -77.38% |
| Dec 30, 2022 | 503.00M | -49.95% |
| Dec 30, 2021 | 1.00B | -36.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Simris Group AB (PUBL) | 141.05M |
| Active Biotech AB | 139.18M |
| NextCell Pharma AB | 126.65M |
| Annexin Pharmaceuticals AB | 91.77M |
| OncoZenge AB | 87.24M |
| Spago Nanomedical AB | 76.08M |
| AcouSort AB | 71.53M |
| Disruptive Pharma AB | 59.21M |